Unlisted Deals:
ador powertron 500.00 (4,900.00 %) aitmc formerly avpl 62.00 (-6.06 %) amol minechem 601.00 (0.17 %) anglo french drugs 950.00 (2.15 %) anugraha valve 525.00 (2.94 %) apl metals 39.00 (-2.50 %) apollo fashion 90.00 (-2.17 %) arohan 250.00 (-1.96 %) assam carbon 330.00 (1.54 %) avalokiteshvar 242.00 (0.83 %) axles india 655.00 (-3.68 %) balmer lawrie 200.00 (-0.99 %) bharat hotels 380.00 (-1.30 %) bima mandi 235.00 (-2.08 %) bira 545.00 (-0.91 %) blsx limited 35.00 (2.94 %) boat 1,600.00 (3.23 %) c & s electric 1,070.00 (1.90 %) cable corporation 11.00 (-8.33 %) capgemini 14,300.00 (-1.38 %) care health 180.00 (-2.17 %) carrier aircon 550.00 (0.92 %) cial 455.00 (-2.15 %) csk 188.00 (-1.05 %) dalmia refract 270.00 (-1.82 %) dfm foods 470.00 (0.64 %) dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 445.00 (1.14 %) electronica plastic 4,500.00 (2.27 %) elgi ultra 400.00 elofic industries 2,850.00 (1.79 %) esl steel 42.00 (-2.33 %) fincare business 87.00 (1.16 %) fincare sfbl 205.00 (1.49 %) finopaytech limited 149.00 (-0.67 %) frick india 3,350.00 (-1.47 %) gkn driveline 1,818.00 (1.00 %) goodluck defence 290.00 (3.57 %) group pharma 300.00 gynofem healthcare 75.00 (2.74 %) hazira cargo terminals limited 205.00 (1.49 %) hdb financial 1,220.00 (-0.41 %) hdfc ergo 370.00 (1.70 %) hdfc securities 10,600.00 (-0.93 %) hella india 900.00 (-2.17 %) hero fincorp 1,950.00 (-0.76 %) hexaware 990.00 (1.02 %) hicks 1,650.00 (3.13 %) hinduja leyland 260.00 hira ferro 200.00 (2.56 %) honeywell electrical 7,600.00 (1.33 %) ikf finance 310.00 (-3.13 %) incred financial 10.00 (1.01 %) incred holdings 153.00 (-1.29 %) india carbon 1,100.00 (-1.79 %) india exposition 121.00 (0.83 %) indian potash 3,150.00 (1.61 %) indian seamless 195.00 (2.63 %) indo alusys 25.75 (-0.96 %) indofil 1,390.00 (-0.71 %) infinite computer 405.00 (1.25 %) inkel 22.00 (-2.22 %) jana small finance bank 75.00 kel 500.00 (-4.76 %) kial 137.00 (-0.72 %) klm axiva 15.50 (3.33 %) kurlon limited 1,275.00 (1.59 %) lava 42.00 (-1.18 %) mahindra rural mrhfl 100.00 manipal housing 74.00 (2.07 %) manjushree technopack 850.00 (-2.86 %) martin & harris 820.00 (-1.20 %) matrix gas 795.00 (-0.63 %) merino 3,300.00 (1.54 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 425.00 (-2.30 %) mohan meakin 2,300.00 (-4.17 %) mohfl 22.00 (4.76 %) msei 4.50 (-5.26 %) msil 34.00 (3.03 %) nayara energy 990.00 (-1.98 %) nayara energy ncd 320.00 (1.59 %) ncdex 199.00 (-1.49 %) ncl buildtek 320.00 (3.23 %) ncl holdings 106.00 (0.95 %) nsdl 1,000.00 (-0.99 %) nse india 1,800.00 (-2.70 %) onix renewable 21,000.00 (2.44 %) orbis financial 420.00 (2.44 %) oswal minerals 60.10 (-1.48 %) otis elevator 4,100.00 (2.50 %) oyo rooms 56.00 (1.82 %) panasonic appliances 270.00 (3.05 %) paymate india 500.00 (-1.96 %) pharmeasy 8.60 (1.78 %) pharmed limited 675.00 (2.27 %) philips domestic 625.00 (-2.34 %) philips india 925.00 (-0.54 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 260.00 (-1.89 %) rapido 16,650.00 (0.03 %) rasoi 82,000.00 (2.50 %) reliance gic 530.00 (1.92 %) resins plastics 575.00 (2.68 %) ring plus aqua 580.00 (3.57 %) rrp s4e innovation 295.00 (-1.67 %) sab miller 535.00 (0.94 %) sbi amc 2,625.00 (-0.19 %) sbi general insurance 621.00 (0.16 %) scottish assam 505.00 (1.00 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,325.00 (-1.85 %) smile microfinance 51.00 (-1.92 %) sterlite grid 5 290.00 (5.45 %) sterlite power 625.00 (0.81 %) studds 1,390.00 (-0.71 %) svsml 315.00 (2.94 %) t stanes 800.00 (1.27 %) tata capital 880.00 (1.15 %) trl krosaki 1,730.00 (-1.14 %) urban tots 64.00 (-1.54 %) utkarsh coreinvest 285.00 (-1.72 %) vikram solar 440.00 (-0.45 %) vivriti capital 1,040.00 (-0.95 %)
×

Ajay Bio-tech Annual Report, Balance Sheet & Financials

Ajay Bio Tech India Limited (Ajay Biotech) Return Comparision with Primex 40 Index

Periods 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years All Time
Primex-40
Ajay Bio Tech India Limited

Ajay Bio-tech (india) Limited Ltd Balance Sheet (Rs in Lakhs)

Particulars

31-03-2024

31-03-2023

Equity

 

 

Share Capital

208.56

208.56

Reserve and Surplus

4,097.53

4,269.94

Non Current Liabilities

 

 

Long term Borrowings

324.68

332.21

Other Long-term liabilities

43.94

42.29

Long term Provisions

85.44

108.96

Current Liabilities

 

 

Short term Borrowings

782.73

434.82

Trade Payable

 

 

Total Outstandings dues to Micro & Small enterprises

117.08

127.23

Total Outstandings dues to creditors other than Micro & Small enterprises

122.67

329.38

Other current liabilities

216.70

445.26

Short term provisions

9.35

3.81

Total Equity and Liabilities

6,008.68

6,302.46

Non-Current Assets

 

 

Property, Plant and Equipment

2,136.01

2,127.75

Intangible assets

3.95

7.17

Capital work in progress

398.37

366.36

Non current Investments

5.50

5.50

Long term loans and advances

100.08

36.66

Other non-current assets

211.57

216.64

Current Assets

 

 

Inventories

727.17

835.55

Trade Receivable

1,621.80

1,522.45

Cash And Cash Equivalents

9.12

71.75

Bank balances other than cash & cash equivalents

30.90

193.84

Short term Loans and Advances

747.54

875.38

Other current assets

16.67

43.41

Total Assets

6,008.68

6,302.46

 

Ajay Bio-tech (india) Limited Ltd Profit & Loss Statement (Rs in Lakhs)

Particulars

2023-24

2022-23

Income

 

 

Revenue from Operation

4,156.32

4,408.16

Other Income

48.99

70.73

Total Revenue

4,205.31

4,478.89

Expenses

 

 

Cost of material consumed

1,553.50

1,787.10

Purchase of stock in trade

38.74

0.28

Changes in Inventories of stock in trade and finished goods

-84.17

83.57

Employee benefit expenses

838.35

1,007.98

Finance Costs

100.56

64.57

Depreciation and Amortization Expenses

119.59

121.09

Other Expenses

1811.14

2,153.53

Total Expenses

4,377.71

5,218.12

Profit before Tax

-172.40

-739.23

Current tax

-

11.81

Deferred tax

-

18.01

Income tax of earlier years

-

29.82

Profit / (Loss) After tax

-172.40

-769.05

Earnings per Equity Share:

 

 

Basic

-4.96

-22.12

Diluted

-4.96

-22.12

 Ajay Bio-tech (india) Limited Ltd Consolidated Cash Flow Statement (Rs in Lakhs) 

Particulars

31-03-2024

31-03-2023

Cash Flow from Operating Activities

 

 

Net Profit before Tax

-172.41

-793.23

Adjustment for:

 

 

Depreciation

119.59

121.09

Sundry Balances written of

12.65

13.60

Provision for Doubtful Debts

43.65

125.24

Provision for Stock Obsolescence

55.63

-

Unspent Liabilities/Sundry balances written back (net)

-2.27

-13.02

Loss / (Gain) on Property, plant & equipment

1.42

0.04

(gain) on property, plant & equipment

-4.31

-

Property, plant & equipment discarded

31.32

-

Unrealised Loss / (Gain) on Foreign Exchange

0.24

0.01

Interest Income

-35.16

-49.89

Interest expenses

91.89

64.57

Operating Profit before Working Capital Charges

142.25

-477.59

Adjustment for:

 

 

(Increase) / Decrease Trade receivables

-155.65

-8.32

(Increase) / Decrease Loans and Advances

127.84

-15.11

(Increase) / Decrease Inventories

52.75

388.97

(Increase) / Decrease Other current & Non-Current assets

50.53

100.02

Increase / (Decrease) Trade Payable

-214.61

336.86

Increase / (Decrease) other current liabilities

-228.80

-423.24

Increase / (Decrease) Short Term / Long Term Provisions

-17.98

3.81

Cash generated from Operations

-243.67

-94.60

Direct taxes paid

18.72

57.89

Net Cash From Operating Activates

-262.38

-152.49

Cash Flow from Investing Activities

 

 

Payment for procurement of PPE and capital advances

-195.44

-298.45

Proceeds from Sale of PPE

10.38

0.01

Deposits/Balances with Banks

162.94

153.61

Interest received

35.16

55.72

Net Cash From Investing Activities

-249.35

-241.60

Cash Flow from Financing Activities

 

 

Proceeds from / Repayments of borrowings

347.91

266.46

Loans and advances

-63.42

-

Repayment of Long-Term Borrowings

-7.53

-8.72

Dealers Security Deposit (net of repayments)

1.65

9.85

Interest paid

-91.89

-64.57

Net Cash From Financing Activities

186.72

203.02

Net Increase /(Decrease) In cash & Cash Equivalents

-62.63

-38.58

Cash  & Cash equivalents at the beginning of the Year

71.75

110.33

Cash  & Cash equivalents at the end of the Year

9.12

71.75

Cash and Cash Equivalents include

 

 

Cash and cheques on Hand

1.71

4.94

Balances with Banks in Current Accounts

7.41

66.81

Total

9.12

71.75

 

Here is a summary of the Cash Flow Statement for the years 2024 and 2023:

Cash Flow from Operating Activities:

Net Profit before Tax:

The company reported a net loss before tax of Rs. 172.41 Lakhs for FY 2023-24 compared to a larger loss of Rs. 793.23 Lakhs in FY 2022-23. This indicates a significant reduction in the operating loss year-over-year, which is a positive sign. The company is moving closer to break-even or profitability in terms of its core business operations.

Adjustments for Non-Cash Items:

The adjustments for non-cash items such as Depreciation (Rs. 119.59 Lakhs), Sundry balances written off (Rs. 12.65 Lakhs), Provision for doubtful debts (Rs. 43.65 Lakhs), and Provision for stock obsolescence (Rs. 55.63 Lakhs) are added back to the net profit. These adjustments reflect non-cash expenses or provisions made to account for potential future losses, impairments, or obsolescence. This is common in financial statements as these expenses don 't represent actual cash outflows but are required for accounting purposes.

The loss/gain on the sale of property, plant & equipment (PPE) and foreign exchange gains/losses are also adjusted. For instance, the net loss on PPE disposal (Rs. 1.42 Lakhs) and foreign exchange loss (Rs. 0.24 Lakhs) are minor adjustments that slightly affect the overall operating cash flow.

Interest Income (Rs. 35.16 Lakhs) is deducted as it’s part of financing activities rather than operating activities. Similarly, Interest Expense (Rs. 91.89 Lakhs) is added back to reflect actual cash outflows related to borrowing costs.

Operating Profit before Working Capital Charges:

After these adjustments, the operating profit before changes in working capital stands at Rs. 142.25 Lakhs for FY 2023-24, a significant recovery from the negative Rs. 477.59 Lakhs in the previous year. This indicates that the core operations of the business are improving, with a reduction in operating losses.

Changes in Working Capital:

Working capital adjustments include changes in trade receivables, loans and advances, inventories, other assets, trade payables, other liabilities, and provisions. These adjustments help to reflect how the company’s operations are funded through its working capital.

The increase in trade receivables (-Rs. 155.65 Lakhs) implies that the company’s customers owe more money at the end of the year, which is a cash outflow.

The increase in loans and advances (Rs. 127.84 Lakhs) suggests that the company is advancing more funds, potentially to suppliers or employees, or investing in other operational areas.

The increase in inventories (Rs. 52.75 Lakhs) is another cash outflow, as the company’s cash is tied up in stock that has not yet been sold.

On the positive side, the decrease in trade payables (-Rs. 214.61 Lakhs) and other current liabilities (-Rs. 228.80 Lakhs) indicate that the company has settled some of its obligations, leading to cash outflows.

Net Cash From Operating Activities:

The overall result from operating activities is a net outflow of Rs. 262.38 Lakhs for FY 2023-24, which is a worsening of cash flow compared to Rs. 152.49 Lakhs outflow in FY 2022-23. Despite the positive operating results, the significant cash outflows from working capital adjustments contributed to the negative cash flow.

 

Cash Flow from Investing Activities:

Investing Cash Flows primarily relate to the company’s purchase and sale of property, plant, and equipment (PPE), as well as interest income received and changes in deposits.

The payment for procurement of PPE and capital advances (-Rs. 195.44 Lakhs) indicates a significant cash outflow as the company has been investing in its assets. This could represent spending on new plant, machinery, or technology.

The proceeds from sale of PPE (Rs. 10.38 Lakhs) are relatively small in comparison, which indicates that the company is not liquidating its assets significantly to fund operations.

The deposits/balances with banks (Rs. 162.94 Lakhs) show a cash inflow, likely due to temporary surplus funds being placed in interest-bearing deposits or investments.

The interest received (Rs. 35.16 Lakhs) reflects the income earned from the company’s cash reserves or investments.

Net Cash From Investing Activities:

The overall result is a net outflow of Rs. 249.35 Lakhs for FY 2023-24, slightly higher than the Rs. 241.60 Lakhs outflow in FY 2022-23. The company is continuing to invest in its physical assets while receiving some income from interest-bearing deposits.

 

Cash Flow from Financing Activities:

Financing Activities include transactions involving the company’s capital structure, such as borrowings and repayments.

The company has borrowed Rs. 347.91 Lakhs in FY 2023-24, which is a significant cash inflow. This likely represents new loans or credit facilities to support its operations or growth.

On the other hand, the repayment of borrowings (-Rs. 7.53 Lakhs) and interest paid (-Rs. 91.89 Lakhs) are outflows related to the company’s existing debt obligations.

Loans and advances (Rs. -63.42 Lakhs) indicate a cash outflow related to advances or loans given to others, which could be for business operations or capital investments.

The dealers ' security deposits (net of repayments) Rs. 1.65 Lakhs is a minor cash inflow.

Net Cash From Financing Activities:

The overall net inflow from financing activities is Rs. 186.72 Lakhs, which is slightly lower than the previous year’s Rs. 203.02 Lakhs. Despite this slight decrease, the company still raised significant funds through borrowing.

 

Net Change in Cash and Cash Equivalents:

The net increase in cash and cash equivalents for FY 2023-24 is Rs. -62.63 Lakhs, indicating a reduction in cash reserves. This is a worsened position compared to the previous year, where the cash decrease was Rs. 38.58 Lakhs.

Cash at the beginning of the year was Rs. 71.75 Lakhs, and at the end of the year, it stands at Rs. 9.12 Lakhs. This large decrease in cash is primarily due to the negative operating and investing cash flows.

 

Financial Ratios of Ajay Bio-tech And Produce Home Finance Limited

Particulars

2023-24

2022-23

Current ratio

2.53

2.64

Debt-equity ratio

0.26

0.17

Debt service coverage ratio

0.13

-1.45

Return on equity ratio

-0.04

-0.17

Inventory turnover ratio

1.86

1.82

Trade receivables turnover ratio

2.64

2.78

Trade payables turnover ratio

4.18

5.03

Net capital turnover ratio

2.18

2

Net profit ratio

-0.04

-0.17

Return on capital employed

-0.03

-0.14

 

 

Here is a summary of the financial and operational metrics for Ajay Bio-tech (india) Limited Ltd for the year 2023-24 & 2022-23:

 

Current Ratio

2023-24: 2.53

2022-23: 2.64

The Current Ratio measures a company 's ability to cover its short-term liabilities with its short-term assets. A ratio above 1 indicates good liquidity, suggesting that the company can meet its current obligations. In 2023-24, the ratio is 2.53, meaning the company has Rs. 2.53 in assets for every Rs. 1 in liabilities. This is a solid liquidity position, although it has slightly decreased from 2.64 in 2022-23.

 

Debt-Equity Ratio

2023-24: 0.26

2022-23: 0.17

The Debt-Equity Ratio shows the proportion of debt used to finance the company’s assets in relation to equity. A lower ratio indicates less reliance on debt, thus lower financial risk. In 2023-24, the ratio is 0.26, meaning the company has Rs. 0.26 of debt for every Rs. 1 of equity.

Debt Service Coverage Ratio (DSCR)

2023-24: 0.13

2022-23: -1.45

The Debt Service Coverage Ratio measures the company’s ability to cover its debt obligations (interest and principal) from its operating income. A ratio above 1 indicates sufficient earnings to meet debt payments. In 2023-24, the ratio is 0.13, which is significantly low and suggests that the company is struggling to generate enough income to meet its debt obligations. It’s an improvement from the -1.45 in 2022-23.

Return on Equity (ROE)

2023-24: -0.04

2022-23: -0.17

Return on Equity measures the profitability of a company in relation to shareholders ' equity. A negative ROE indicates that the company is incurring losses relative to its equity. In 2023-24, the ROE is -0.04, meaning the company lost Rs. 0.04 for every Rs. 1 of equity invested. While still negative, this is an improvement from -0.17 in 2022-23, where the company was losing Rs. 0.17 for every Rs. 1 of equity

Inventory Turnover Ratio

2023-24: 1.86

2022-23: 1.82

The Inventory Turnover Ratio measures how efficiently a company sells and replaces its inventory. A higher ratio indicates better inventory management and quicker sales. In 2023-24, the ratio is 1.86, which is a slight improvement over 1.82 in 2022-23. This suggests that the company has become marginally more efficient in managing its inventory.

Trade Receivables Turnover Ratio

2023-24: 2.64

2022-23: 2.78

The Trade Receivables Turnover Ratio measures how often the company collects its accounts receivable during the year. A higher ratio indicates quicker collection of payments from customers, improving cash flow. In 2023-24, the ratio is 2.64, a slight decrease from 2.78 in 2022-23.

Trade Payables Turnover Ratio

2023-24: 4.18

2022-23: 5.03

The Trade Payables Turnover Ratio measures how quickly the company pays its suppliers. A higher ratio indicates faster payment, while a lower ratio suggests the company is taking longer to pay its creditors. In 2023-24, the ratio is 4.18, a decrease from 5.03 in 2022-23.

Net Capital Turnover Ratio

2023-24: 2.18

2022-23: 2

The Net Capital Turnover Ratio measures the company’s ability to generate revenue from its capital base (both equity and debt). A higher ratio indicates better utilization of capital. In 2023-24, the ratio is 2.18, a slight improvement from 2 in 2022-23, meaning the company is generating more revenue per unit of capital employed.

Net Profit Ratio

2023-24: -0.04

2022-23: -0.17

The Net Profit Ratio measures the company’s profitability as a percentage of its total revenue. A negative net profit ratio indicates a loss. In 2023-24, the ratio is -0.04, meaning the company lost Rs. 0.04 for every Rs. 1 of sales. This is an improvement from -0.17 in 2022-23

Return on Capital Employed (ROCE)

2023-24: -0.03

2022-23: -0.14

Return on Capital Employed measures how effectively the company uses its capital (equity and debt) to generate profits. A negative ROCE indicates inefficient capital usage. In 2023-24, the ROCE is -0.03, which is an improvement from -0.14 in 2022-23, meaning the company is losing less in relation to the capital employed.

Ajay Bio-tech Annual Report

Ajay Bio-tech Annual Report 2023-24

Download

Ajay Bio-tech Annual Report 2022-23

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha

News Alert